Home Financial Markets Pieris Pharmaceuticals Inc. (PIRS) Stock Price Is Rising, Here is What You...

Pieris Pharmaceuticals Inc. (PIRS) Stock Price Is Rising, Here is What You Need to Know

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company committed to the discovery and development of Anticalinbased drugs that target validated disease pathways, announced that it is part of a multi-program research collaboration and license agreement with Genentech. PIRS stock price surged immensely adjacent to the news.

Pieris Pharmaceuticals Inc. (PIRS) shares were rising 44.86% to trade at $2.68 in the current market trading today. In the past 12 months, the company’s stock has retreated -39.74%, and in the last week, the stock has moved down -3.65%.  PIRS’s stock closed the last session at $1.85.Shares of the company were fluctuating between $1.84 and $1.96. Furthermore, the company has a current market of $112.81 million and its outstanding shares stood at 56.30 million.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

About Collaboration

Genentech is a member of the Roche Group which specializes to discover, produce and commercialize locally delivered respiratory and ophthalmology therapies that use Pieris’ proprietary Anticalintechnology.

The research collaboration will allow Pieris to leverage its revolutionary discovery engine with Genentech’s targets, as well as its preclinical and clinical development skill, to generate unique therapies to treat respiratory and ophthalmological disorders. The emphasized upon areas of the collaboration are complementary in nature and provide several advantages offered by the compact size of Anticalin proteins when delivered locally.

In accordance to the terms and conditions of the agreement, Pieris will obtain $20 million as an upfront payment and can potentially be eligible to get more than $1.4 billion in additional milestone payments among several programs, as well as receive royalties for commercialized programs.

Pieris objective will be inclusive of discovery research and early preclinical development of the trials and program, and Genentech will use its skillset for IND-enabling activities, clinical development, and commercialization of the trials and programs. Genentech will also consist of the option to select excessive targets in return for an optional exercise fee. The collaboration is not inclusive of any of Pieris’ internal programs

This collaboration helps to further extent partnered efforts in respiratory diseases and initiates a new direction for Anticalin technology to for potentially producing patient benefit from local biological effects.

Conclusion

PIRS collaboration with Genentech surpassed investor expectation with PIRS stock prince increasing immensely at current trading. Furthermore, potential eligibility for capital within the range of $1.4B has further increased interest for Pieris Pharmaceuticals, Inc.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Tiziana Life Sciences Inc. (TLSA) stock surged during pre-market. Let’s see why?

Tiziana Life Sciences Inc. (NASDAQ: TLSA) stock declined by 2.54% at last close however the TLSA stock price depicts a rise of 8.26% during...

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen...

Related News

Orphazyme Inc. (ORPH) stock plunged during pre-market trading. Let’s see why?

Orphazyme Inc. (NASDAQ: ORPH) stock declined by 10.18% at last close whereas the ORPH stock price fell during the pre-market trading session by 58.18%....

SPI Energy Inc. (SPI) stock surged in the current market trading. Here’s the update

SPI Energy Inc. (NASDAQ: SPI) stock soars by 15.42% during the current market trading session. SPI Energy is an international renewable energy company that...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

General Employment Enterprises Inc. (JOB) stock soars during pre-market trading. Here’s to know why?

General Employment Enterprises Inc. (NASDAQ: JOB) stock gained by 1.96% at last close while the JOB stock price rises by 3.88% in the pre-market...

U.S Concrete Inc. (USCR) stock soars during pre-market trading session. What’s driving it high?

U.S Concrete Inc. (NASDAQ: USCR) stock declined by 0.66% at last close while the USCR stock price gained by 27.88% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

7542

GIFT

Download free eBook for 

7 GROWTH  STOCKS FOR 2021

WAIT 
WE HAVE GIFT FOR YOU

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam